Literature DB >> 6941824

Individual nuclear uptake patterns for adriamycin and daunomycin in human leukemia and lymphoma cells.

S Seeber, H Loth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6941824     DOI： 10.1007/bf00996898

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  25 in total

1.  Therapy of acute myelogeneous leukemia.

Authors:  E J Freireich; M J Keating; E A Gehan; K B McCredie; G P Bodey; T Smith
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

2.  Letter: Adriamycin in acute leukaemia.

Authors:  I E Smith; T J McElwain
Journal:  Lancet       Date:  1974-07-20       Impact factor: 79.321

3.  Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.

Authors:  K Dano
Journal:  Biochim Biophys Acta       Date:  1973-10-25

4.  Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response.

Authors:  D Kessel; V Botterill; I Wodinsky
Journal:  Cancer Res       Date:  1968-05       Impact factor: 12.701

5.  Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods.

Authors:  N R Bachur; A L Moore; J G Bernstein; A Liu
Journal:  Cancer Chemother Rep       Date:  1970-04

6.  Acute myelocytic leukemia.

Authors:  J F Holland; O Glidewell; R R Ellison; R W Corey; J Schwartz; H J Wallace; H C Hoagland; P Wiernik; K Rai; J G Bekesi; J Cuttner
Journal:  Arch Intern Med       Date:  1976-12

7.  Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.

Authors:  G Noel; C Peterson; A Trouet; P Tulkens
Journal:  Eur J Cancer       Date:  1978-04       Impact factor: 9.162

8.  Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells.

Authors:  C Paul; C Peterson; G Gahrton; D Lockner
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

9.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

10.  Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.

Authors:  D S Chervinsky; J J Wang
Journal:  J Med       Date:  1976
View more
  4 in total

1.  Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells.

Authors:  M W DeGregorio; G M Lui; B A Macher; J R Wilbur
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

2.  Kinetics and sensitivity of daunorubicin in patients with acute leukemia.

Authors:  M W DeGregorio; W M Holleran; B A Macher; C A Linker; J R Wilbur
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Uptake and metabolism of daunorubicin by human leukemia cells.

Authors:  M W DeGregorio; C J Carrera; J C Klock; J R Wilbur
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

4.  Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy.

Authors:  A T McGown; D Murphy; D Crowther; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.